TR201916902A2 - PROTEIN DETECTION USING LENSLESS HOLOGRAPHIC MICROSCOPY IMAGING TECHNIQUE IN A MAGNETIC LEVITATION DEVICE - Google Patents

PROTEIN DETECTION USING LENSLESS HOLOGRAPHIC MICROSCOPY IMAGING TECHNIQUE IN A MAGNETIC LEVITATION DEVICE Download PDF

Info

Publication number
TR201916902A2
TR201916902A2 TR2019/16902A TR201916902A TR201916902A2 TR 201916902 A2 TR201916902 A2 TR 201916902A2 TR 2019/16902 A TR2019/16902 A TR 2019/16902A TR 201916902 A TR201916902 A TR 201916902A TR 201916902 A2 TR201916902 A2 TR 201916902A2
Authority
TR
Turkey
Prior art keywords
magnetic levitation
imaging technique
protein detection
levitation device
microscopy imaging
Prior art date
Application number
TR2019/16902A
Other languages
Turkish (tr)
Inventor
Yaman Sena
Deli̇koyun Kerem
Cumhur Teki̇n Hüseyi̇n
Original Assignee
Izmir Yueksek Teknoloji Enstituesue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Izmir Yueksek Teknoloji Enstituesue filed Critical Izmir Yueksek Teknoloji Enstituesue
Priority to TR2019/16902A priority Critical patent/TR201916902A2/en
Priority to PCT/TR2020/051002 priority patent/WO2021086293A2/en
Publication of TR201916902A2 publication Critical patent/TR201916902A2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/41—Refractivity; Phase-affecting properties, e.g. optical path length
    • G01N21/45—Refractivity; Phase-affecting properties, e.g. optical path length using interferometric methods; using Schlieren methods
    • G01N21/453—Holographic interferometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47—Scattering, i.e. diffuse reflection
    • G01N21/4788—Diffraction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01—Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03—Cuvette constructions
    • G01N2021/0346—Capillary cells; Microcells

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

Buluş, manyetik levitasyon platformuna entegre edilen merceksiz holografik mikroskop görüntüleme tekniği ile biyomolekül tespit edilmesi ile ilgilidir.The invention relates to the detection of biomolecules with the lensless holographic microscope imaging technique integrated into the magnetic levitation platform.

TR2019/16902A 2019-11-01 2019-11-01 PROTEIN DETECTION USING LENSLESS HOLOGRAPHIC MICROSCOPY IMAGING TECHNIQUE IN A MAGNETIC LEVITATION DEVICE TR201916902A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2019/16902A TR201916902A2 (en) 2019-11-01 2019-11-01 PROTEIN DETECTION USING LENSLESS HOLOGRAPHIC MICROSCOPY IMAGING TECHNIQUE IN A MAGNETIC LEVITATION DEVICE
PCT/TR2020/051002 WO2021086293A2 (en) 2019-11-01 2020-10-27 Protein detection using lensless holographic microscopy imaging technique in a magnetic levitation setup

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/16902A TR201916902A2 (en) 2019-11-01 2019-11-01 PROTEIN DETECTION USING LENSLESS HOLOGRAPHIC MICROSCOPY IMAGING TECHNIQUE IN A MAGNETIC LEVITATION DEVICE

Publications (1)

Publication Number Publication Date
TR201916902A2 true TR201916902A2 (en) 2021-05-21

Family

ID=75716199

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/16902A TR201916902A2 (en) 2019-11-01 2019-11-01 PROTEIN DETECTION USING LENSLESS HOLOGRAPHIC MICROSCOPY IMAGING TECHNIQUE IN A MAGNETIC LEVITATION DEVICE

Country Status (2)

Country Link
TR (1) TR201916902A2 (en)
WO (1) WO2021086293A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015095395A1 (en) * 2013-12-17 2015-06-25 The General Hospital Corporation Microfluidic devices for isolating particles
CA2940650C (en) * 2014-02-26 2022-10-04 Brigham And Women's Hospital, Inc. System and method for cell levitation and monitoring

Also Published As

Publication number Publication date
WO2021086293A2 (en) 2021-05-06
WO2021086293A3 (en) 2021-06-17

Similar Documents

Publication Publication Date Title
CL2018003520A1 (en) Anti-b7-h3 antibodies and antibody and drug conjugates.
ES2500066T3 (en) Ferroportin antibodies and methods of use
MX2016004579A (en) Tm4sf1 binding proteins and methods of using same.
BR112016014022A2 (en) anti-cd3 antibodies, isolated nucleic acid, vector, host cell, anti-cd3 antibody production method, immunoconjugate, composition, use of anti-cd3 antibody, treatment methods, methods of enhancing immune function and kit
MX2019003168A (en) ANTIBODIES AGAINST SIGNAL REGULATING ALPHA PROTEIN AND METHODS OF USE.
CL2019000082A1 (en) Specific antibodies for hyperphosphorylated tau and its methods of use.
GT201700162A (en) ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BIESPECIFIC ANTIBODIES THAT SPECIFICALLY JOIN CD3 AND / OR CD123
CL2020000977A1 (en) Drug-activatable anti-cd71 antibody conjugates and methods of using these.
DOP2015000243A (en) ANTI-LAG-3 UNION PROTEINS
CR20240116A (en) FLT3 CHIMERIC RECEPTORS AND METHODS OF USING THEM (Divisional 2018-518)
CL2017000278A1 (en) Bispecific t-cell activating antigen binding molecules
EA201690299A1 (en) STABILIZATION OF Fc-CONTAINING POLYPEPTIDES
MX2017011281A (en) Amatoxin-antibody conjugates.
MX384006B (en) TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS AND METHODS OF USING THEM.
CL2015002756A1 (en) Bispecific fc molecules
MX2015017331A (en) ANTIBODIES ANTI FC SIMILAR TO RECEIVER 5 (FCRH5).
BR112018075653A2 (en) anti-b7-h3 antibodies and drug antibody conjugates
CO6700829A2 (en) Novel modulators and methods of use
CL2017002756A1 (en) Acrylic emulsion adhesives
MX2015012825A (en) MONOCLONAL ANTIBODIES OF THE LIPIDO UNION DOMAIN OF THE HEPATITIS C VHC VIRUS CORE.
MX381364B (en) SURFACE ACTIVE AGENTS BASED ON ALIPHATIC POLYCARBONATE.
MX2016006551A (en) Preparing antibodies from cho cell cultures for conjugation.
MX2019001853A (en) Hydrocarbon fluid-water separation.
EP3805390A4 (en) NAV1.7 MONOCLONAL ANTIBODY
MX2018013484A (en) NEW ANTI-TNFRSF21 ANTIBODIES AND MODES OF USE.